Genetic variant reclassification process followed at Pathway Genomics is outlined in the diagram shown below.
- Classification of genetic variants is re-evaluated either every six months after last classification or when new scientific evidence is available, whatever happens first.
- The findings are approved by Pathway Genomics Clinical Review Committee.
- If the variant is reclassified then: (a) a new report is issued for all relevant cases, (b) the treating physician(s) are contacted to discuss the change, and (c) the reclassification is communicated to the community through re-submission to ClinVar and posting on Pathway Genomics website.
